147 related articles for article (PubMed ID: 23578757)
1. Neuropeptide FF attenuates the acquisition and the expression of conditioned place aversion to endomorphin-2 in mice.
Han ZL; Wang ZL; Tang HZ; Li N; Fang Q; Li XH; Yang XL; Zhang XY; Wang R
Behav Brain Res; 2013 Jul; 248():51-6. PubMed ID: 23578757
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide FF (NPFF) reduces the expression of morphine- but not of ethanol-induced conditioned place preference in rats.
Kotlinska J; Pachuta A; Dylag T; Silberring J
Peptides; 2007 Nov; 28(11):2235-42. PubMed ID: 17884254
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of EN-9, a novel chimeric peptide of endomorphin-2 and neuropeptide FF that produces potent antinociceptive activity and limited tolerance.
Wang ZL; Li N; Wang P; Tang HH; Han ZL; Song JJ; Li XH; Yu HP; Zhang T; Zhang R; Xu B; Zhang MN; Fang Q; Wang R
Neuropharmacology; 2016 Sep; 108():364-72. PubMed ID: 26970017
[TBL] [Abstract][Full Text] [Related]
4. A neuropeptide FF agonist blocks the acquisition of conditioned place preference to morphine in C57Bl/6J mice.
Marchand S; Betourne A; Marty V; Daumas S; Halley H; Lassalle JM; Zajac JM; Frances B
Peptides; 2006 May; 27(5):964-72. PubMed ID: 16494968
[TBL] [Abstract][Full Text] [Related]
5. Differential conditioned place preference responses to endomorphin-1 and endomorphin-2 microinjected into the posterior nucleus accumbens shell and ventral tegmental area in the rat.
Terashvili M; Wu HE; Leitermann RJ; Hung KC; Clithero AD; Schwasinger ET; Tseng LF
J Pharmacol Exp Ther; 2004 May; 309(2):816-24. PubMed ID: 14755004
[TBL] [Abstract][Full Text] [Related]
6. The influence of a new derivate of kisspeptin-10 - Kissorphin (KSO) on the rewarding effects of morphine in the conditioned place preference (CPP) test in male rats.
Gibula-Tarlowska E; Kedzierska E; Piechura K; Silberring J; Kotlinska JH
Behav Brain Res; 2019 Oct; 372():112043. PubMed ID: 31226311
[TBL] [Abstract][Full Text] [Related]
7. Modulation of neuropeptide FF (NPFF) receptors influences the expression of amphetamine-induced conditioned place preference and amphetamine withdrawal anxiety-like behavior in rats.
Kotlinska JH; Gibula-Bruzda E; Koltunowska D; Raoof H; Suder P; Silberring J
Peptides; 2012 Jan; 33(1):156-63. PubMed ID: 22197492
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide FF receptors antagonist, RF9, attenuates opioid-evoked hypothermia in mice.
Wang YQ; Guo J; Wang SB; Fang Q; He F; Wang R
Peptides; 2008 Jul; 29(7):1183-90. PubMed ID: 18406009
[TBL] [Abstract][Full Text] [Related]
9. Opposite conditioned place preference responses to endomorphin-1 and endomorphin-2 in the mouse.
Wu HE; MacDougall RS; Clithero AD; Leitermann RJ; Terashvili M; Tseng LF
Neurosci Lett; 2004 Jul; 365(3):157-61. PubMed ID: 15246539
[TBL] [Abstract][Full Text] [Related]
10. Peripheral and central sites of action for anti-allodynic activity induced by the bifunctional opioid/NPFF receptors agonist BN-9 in inflammatory pain model.
Zhang R; Xu B; Zhang MN; Zhang T; Wang ZL; Zhao G; Zhao GH; Li N; Fang Q; Wang R
Eur J Pharmacol; 2017 Oct; 813():122-129. PubMed ID: 28755985
[TBL] [Abstract][Full Text] [Related]
11. Intracerebroventricular Neuropeptide FF Diminishes the Number of Apneas and Cardiovascular Effects Produced by Opioid Receptors' Activation.
Wojciechowski P; Andrzejewski K; Kaczyńska K
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255594
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide FF (NPFF) reduces the expression of cocaine-induced conditioned place preference and cocaine-induced sensitization in animals.
Kotlinska J; Pachuta A; Silberring J
Peptides; 2008 Jun; 29(6):933-9. PubMed ID: 18295932
[TBL] [Abstract][Full Text] [Related]
13. Effects of neuropeptide FF and related peptides on the antinociceptive activities of VD-hemopressin(α) in naive and cannabinoid-tolerant mice.
Pan JX; Wang ZL; Li N; Zhang N; Wang P; Tang HH; Zhang T; Yu HP; Zhang R; Zheng T; Fang Q; Wang R
Eur J Pharmacol; 2015 Nov; 767():119-25. PubMed ID: 26472125
[TBL] [Abstract][Full Text] [Related]
14. Central administration of neuropeptide FF and related peptides attenuate systemic morphine analgesia in mice.
Fang Q; Jiang TN; Li N; Han ZL; Wang R
Protein Pept Lett; 2011 Apr; 18(4):403-9. PubMed ID: 21121889
[TBL] [Abstract][Full Text] [Related]
15. Different motivational effects induced by the endogenous mu-opioid receptor ligands endomorphin-1 and -2 in the mouse.
Narita M; Ozaki S; Ioka M; Mizoguchi H; Nagase H; Tseng LF; Suzuki T
Neuroscience; 2001; 105(1):213-8. PubMed ID: 11483313
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide S inhibits the acquisition and the expression of conditioned place preference to morphine in mice.
Li W; Gao YH; Chang M; Peng YL; Yao J; Han RW; Wang R
Peptides; 2009 Feb; 30(2):234-40. PubMed ID: 18992779
[TBL] [Abstract][Full Text] [Related]
17. Opposite effects of neuropeptide FF on central antinociception induced by endomorphin-1 and endomorphin-2 in mice.
Wang ZL; Fang Q; Han ZL; Pan JX; Li XH; Li N; Tang HH; Wang P; Zheng T; Chang XM; Wang R
PLoS One; 2014; 9(8):e103773. PubMed ID: 25090615
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of neuropeptide FF (NPFF)-induced hypothermia and anti-morphine analgesia by RF9, a new selective NPFF receptors antagonist.
Fang Q; Wang YQ; He F; Guo J; Guo J; Chen Q; Wang R
Regul Pept; 2008 Apr; 147(1-3):45-51. PubMed ID: 18276024
[TBL] [Abstract][Full Text] [Related]
19. Anoretic effects of neuropeptide FF are mediated via central mu and kappa subtypes of opioid receptors and receptor ligands.
Cline MA; Mathews DS
Gen Comp Endocrinol; 2008; 159(2-3):125-9. PubMed ID: 18823989
[TBL] [Abstract][Full Text] [Related]
20. BN-9, a chimeric peptide with mixed opioid and neuropeptide FF receptor agonistic properties, produces nontolerance-forming antinociception in mice.
Li N; Han ZL; Wang ZL; Xing YH; Sun YL; Li XH; Song JJ; Zhang T; Zhang R; Zhang MN; Xu B; Fang Q; Wang R
Br J Pharmacol; 2016 Jun; 173(11):1864-80. PubMed ID: 27018797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
